Literature DB >> 2759843

Cognitive behavioral treatment of chronic headache: group versus individual treatment format.

P R Johnson, B E Thorn.   

Abstract

Two hypotheses were tested in this study: (1) that a short course of cognitive behavioral therapy (CBT) is effective in the treatment of chronic headache; and (2) that group CT is as effective as individually administered CBT. Twenty-two chronic headache sufferers were randomly assigned to one of three treatment conditions: group administered CBT, individually administered CBT, or no treatment (wait list) control. Wait list subjects ultimately received treatment identical to that offered to subjects in the group treatment condition. Treatment outcome measures included the Brief Symptom Inventory, the McGill Pain Questionnaire, and several measures calculated from self-monitoring data. Tentative support was found for the hypothesis that CBT as provided in this study is effective in the treatment of chronic headache. There was no evidence that group versus individually treated subjects differed significantly on any of the measures used, although the small N and large variance among subjects limit us to preliminary conclusions for our findings. Clinical implications and suggestions for future research are discussed.

Entities:  

Mesh:

Year:  1989        PMID: 2759843     DOI: 10.1111/j.1526-4610.1989.hed2906358.x

Source DB:  PubMed          Journal:  Headache        ISSN: 0017-8748            Impact factor:   5.887


  3 in total

1.  Group versus individual phone-based obesity treatment for rural women.

Authors:  Christie A Befort; Joseph E Donnelly; Debra K Sullivan; Edward F Ellerbeck; Michael G Perri
Journal:  Eat Behav       Date:  2009-08-15

2.  Behavioural management of migraine.

Authors:  Helen Brown; Craig Newman; Rupert Noad; Stuart Weatherby
Journal:  Ann Indian Acad Neurol       Date:  2012-08       Impact factor: 1.383

3.  Cognitive behavioral group intervention for pain and well-being in children with juvenile idiopathic arthritis: a study of feasibility and preliminary efficacy.

Authors:  Johanne Jeppesen Lomholt; Mikael Thastum; Anne Estmann Christensen; Anne Leegaard; Troels Herlin
Journal:  Pediatr Rheumatol Online J       Date:  2015-08-21       Impact factor: 3.054

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.